Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis ; volume:8 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-10 ; date:12.2024
BMC Rheumatology ; 8, Heft 1 (10.9.2024), 1-10, 12.2024
- Creator
-
Adami, Giovanni
Orsolini, Giovanni
Rossini, Maurizio
Fratucello, Anna
Fassio, Angelo
Viapiana, Ombretta
Fracassi, Elena
Bixio, Riccardo
Gatti, Davide
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-024-00414-6
- URN
-
urn:nbn:de:101:1-2411242102147.886879711212
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adami, Giovanni
- Orsolini, Giovanni
- Rossini, Maurizio
- Fratucello, Anna
- Fassio, Angelo
- Viapiana, Ombretta
- Fracassi, Elena
- Bixio, Riccardo
- Gatti, Davide
- SpringerLink (Online service)
Other Objects (12)
Changes in bone turnover markers and bone modulators during abatacept treatment
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Bone microarchitecture and bone turnover in hepatic cirrhosis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Circulating markers of bone turnover
Circulating markers of bone turnover
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Type 2 diabetes affects bone cells precursors and bone turnover
The hidden cross talk between bone and tissues through bone turnover
A collagen membrane influences bone turnover marker in vivo after bone augmentation with xenogenic bone
Clinical cases - Bone turnover markers + vitamin D
Changes in bone turnover markers and bone modulators during abatacept treatment
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Bone microarchitecture and bone turnover in hepatic cirrhosis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Circulating markers of bone turnover
Circulating markers of bone turnover
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Type 2 diabetes affects bone cells precursors and bone turnover
The hidden cross talk between bone and tissues through bone turnover
A collagen membrane influences bone turnover marker in vivo after bone augmentation with xenogenic bone
Clinical cases - Bone turnover markers + vitamin D
Changes in bone turnover markers and bone modulators during abatacept treatment
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Bone microarchitecture and bone turnover in hepatic cirrhosis
Impact of JAK inhibitors tofacitinib and baricitinib on bone turnover during steady-state and pathological conditions
Circulating markers of bone turnover
Circulating markers of bone turnover
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
Type 2 diabetes affects bone cells precursors and bone turnover
The hidden cross talk between bone and tissues through bone turnover
A collagen membrane influences bone turnover marker in vivo after bone augmentation with xenogenic bone